Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Retained Earnings: 2020-2024

Historic Retained Earnings for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $140.9 million.

  • Maravai Lifesciences Holdings' Retained Earnings fell 72.54% to $45.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year decrease of 72.54%. This contributed to the annual value of $140.9 million for FY2024, which is 50.69% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Retained Earnings stood at $140.9 million for FY2024, which was down 50.69% from $285.7 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Retained Earnings peaked at $404.8 million during FY2022, and registered a low of $854,000 during FY2020.
  • Moreover, its 3-year median value for Retained Earnings was $285.7 million (2023), whereas its average is $277.1 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Retained Earnings spiked by 21,511.36% in 2021, and later tumbled by 50.69% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Retained Earnings (Yearly) stood at $854,000 in 2020, then surged by 21,511.36% to $184.6 million in 2021, then spiked by 119.31% to $404.8 million in 2022, then dropped by 29.41% to $285.7 million in 2023, then crashed by 50.69% to $140.9 million in 2024.